Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
7.86
+0.57 (7.82%)
At close: Mar 20, 2026, 4:00 PM EDT
7.84
-0.02 (-0.25%)
After-hours: Mar 20, 2026, 4:15 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $29.48 million as of March 20, 2026. Its market cap has decreased by -26.27% in one year.
Market Cap
29.48M
Enterprise Value
-69.50M
1-Year Change
-26.27%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $29.48M, a decrease of -93.09%. That is a compound annual growth rate of -45.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 38.25M | 13.80% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 30.53M |
| CEL-SCI | 30.36M |
| Tiziana Life Sciences | 29.94M |
| Tempest Therapeutics | 29.12M |
| Outlook Therapeutics | 29.07M |
| Kyntra Bio | 28.53M |
| Exicure | 28.24M |
| Dyadic International | 28.23M |